Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | CYMABAY THERAPEUTICS INC CBAY | Commodore Capital LP | 5,738,500 6.800% | 318,604 (+5.88%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | IMMUNIC INC IMUX | Commodore Capital LP | 287,356 6.300% | -89,302 (-23.71%) | Filing History |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | CELCUITY INC CELC | Commodore Capital LP | 2,257,412 9.900% | 1,336,948 (+145.25%) | Filing History |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Commodore Capital LP | 2,732,567 5.900% | 1,361,228 (+99.26%) | Filing History |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 4,926,000 7.000% | 2,644,685 (+115.93%) | Filing History |
| 2023-01-13 4:05 pm Purchase | 2023-01-03 | 13G | CABALETTA BIO INC CABA | Commodore Capital LP | 1,458,367 5.000% | 1,458,367 (New Position) | Filing History |
| 2022-11-16 4:10 pm Sale | 2022-11-14 | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | Commodore Capital LP | 0 0.000% | -3,711,286 (Position Closed) | Filing History |
| 2022-10-24 4:31 pm Purchase | 2022-10-13 | 13G | IMARA INC IMRA | Commodore Capital LP | 1,497,910 5.700% | 1,497,910 (New Position) | Filing History |
| 2022-10-21 5:15 pm Purchase | 2022-10-12 | 13G | IMMUNIC INC IMUX | Commodore Capital LP | 376,658 9.300% | 376,658 (New Position) | Filing History |
| 2022-05-19 4:30 pm Purchase | 2022-05-09 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Commodore Capital LP | 1,371,339 5.000% | 1,371,339 (New Position) | Filing History |
| 2022-05-16 4:30 pm Purchase | 2022-05-06 | 13G | MERUS N V COM MRUS | Commodore Capital LP | 2,242,224 5.100% | 2,242,224 (New Position) | Filing History |
| 2022-05-09 4:30 pm Purchase | 2022-04-27 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Commodore Capital LP | 267,403 5.100% | 267,403 (New Position) | Filing History |
| 2022-04-14 4:42 pm Purchase | 2022-04-04 | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Commodore Capital LP | 348,530 5.100% | 348,530 (New Position) | Filing History |
| 2022-02-14 4:10 pm Purchase | 2021-12-31 | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | Commodore Capital LP | 3,711,286 11.800% | 502,525 (+15.66%) | Filing History |
| 2022-02-14 4:09 pm Purchase | 2021-12-31 | 13G | GENOCEA BIOSCIENCES INC NE GNCA | Commodore Capital LP | 3,079,756 5.400% | 208,132 (+7.25%) | Filing History |
| 2022-02-14 4:08 pm Purchase | 2021-12-31 | 13G | CYMABAY THERAPEUTICS INC CBAY | Commodore Capital LP | 5,419,896 7.800% | 1,890,431 (+53.56%) | Filing History |
| 2022-02-14 4:07 pm Purchase | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 2,281,315 5.700% | 139,976 (+6.54%) | Filing History |
| 2022-02-14 4:06 pm Purchase | 2021-12-31 | 13G | CELCUITY INC CELC | Commodore Capital LP | 920,464 6.200% | 89,497 (+10.77%) | Filing History |
| 2022-02-14 4:04 pm Purchase | 2022-02-04 | 13G | BELLUS HEALTH INC BLU | Commodore Capital LP | 5,457,110 5.300% | 5,457,110 (New Position) | Filing History |
| 2021-11-03 5:31 pm Purchase | 2021-10-07 | 13G | COGENT BIOSCIENCES INC COGT | Commodore Capital LP | 2,141,339 5.400% | 2,141,339 (New Position) | Filing History |